Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 8Psoriasis 7Lymphoma, Follicular 4Leukemia 4Myelodysplastic Syndromes 3Asthma 3Vasculitis 2Respiratory Distress Syndrome 2Recurrence 2Pneumonia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Inflammation 2Granulomatosis with Polyangiitis 2Bronchiolitis Obliterans 2Arthritis, Psoriatic 2Arthritis, Juvenile 2Wilms Tumor 1Uveitis 1Temporomandibular Joint Disorders 1Spondylitis, Ankylosing 1Spondylarthritis 1Pruritus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plaque, Amyloid 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms 1Metabolic Syndrome 1

Interventions

Exercise 5Vitamin D 2Tea 2Sufentanil 2Spironolactone 2Probiotics 2Oxycodone 2Omeprazole 2Morphine 2Metformin 2Etanercept 2Colchicine 2Ascorbic Acid 2ziprasidone 1soybean oil, phospholipid emulsion 1salicylsalicylic acid 1ginger extract 1falcarinol 1falcarindiol 1epigallocatechin gallate 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Sulindac 1Sodium Salicylate 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Inflammation × Etanercept × Clear all
NCT00111956 2017-10-06

Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 2/3 Completed
56 enrolled

Inflammation, Metabolic Syndrome

NCT00001862 2008-03-04

TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
15 enrolled

Arthritis, Juvenile, Inflammation, Uveitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡